 levels serum interferon-gamma pulmonary sarcoidosis relationship response therapy aim study serum levels lymphokine interferon-gamma IFNg patients chronic pulmonary sarcoidosis value predictive marker clinical response therapy Twenty-five patients age-matched control subjects patients parenchymal shadows Stage II Stage III none clinical evidence extrathoracic disease therapy serum IFNg levels patient group values normal range oral treatment corticosteroids median months range months levels falls patients outcome terms complete radiographic resolution forced vital capacity equal prognostic value pretreatment serum IFNg significant relationship pretreatment levels grades radiographic abnormality yr commencement treatment addition patients steroids remission pretreatment serum IFNg levels incomplete resolution parenchymal shadows radiographic relapses elevated levels IFNg detectable untreated patients Stage II/III pulmonary sarcoidosis patients levels chance complete resolution corticosteroid therapy